This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

Verve Therapeutics’ stock rallies by a record 80% on Eli Lilly’s premium purchase price for the drug-development company.

Related Posts

Spirit Airlines scraps plan to furlough up to 365 pilots

Spirit Airlines scraps plan to furlough up to 365 pilots

Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares for $75,400

Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares...

Enanta Pharma chief medical officer sells $11k in stock

Enanta Pharma chief medical officer sells $11k in stock

The Fed is running into a wall of its own making ahead of next week’s interest-rate vote

The Fed is running into a wall of its own making ahead ...

SpaceX may be worth more than half of Tesla — with a sixth of the revenue

SpaceX may be worth more than half of Tesla — with a si...

Enanta Pharma CBO Luu sells $19,836 in stock

Enanta Pharma CBO Luu sells $19,836 in stock